NEW YORK, Oct. 3, 2012 /PRNewswire/ -- According to BreastCancer.org, 30% of cancers in women are breast cancers, making it the second most diagnosed cancer among women in America. Although the disease is readily talked about, there are some side effects that remain undisclosed to patients.
Since most cases of breast cancer are fueled by the hormone estrogen, when women undergo treatment, it is common for them to take medications to suppress their estrogen production. As a result, pre-menopausal women taking these medications experience the same symptoms as if they were going through menopause, including vulvar dryness and sensitivity. Due to the discomfort, sexual intercourse is often painful, thus affecting intimacy and self-esteem.
Without estrogen, the vulva becomes dry and more susceptible to irritation. Feminine moisturizers and lubricants can help with painful intercourse, but they do not restore balance to the vulvar skin. NeoGyn Vulvar Soothing Cream is formulated with cutaneous lysate, discovered through years of research in wound healing, to help provide comfort and restore the delicate vulvar skin as a result of breast cancer treatment. Free of hormones, NeoGyn is an option for women with breast cancer to help soothe the common discomforts.
Neogyn® Vulvar Soothing Cream is a cosmetic product to help soothe and comfort the vulva. Formulated with Cutaneous Lysate, a naturally balanced blend of proteins discovered in Switzerland, the product is non-greasy, fast absorbing and free of color additives, fragrances and analgesics. Recommended by physicians and women's health professionals, Neogyn® has a unique, patent pending blend of naturally balanced proteins that help restore well-being and comfort with twice daily use over a period of at least 6 to 8 weeks.